Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Group 1 - The presentation is led by Thermo Fisher's CEO, Marc Casper, at the JPMorgan Healthcare Conference, focusing on the company's progress and future goals [1][2] - The company aims to provide an overview of its performance in 2025 and outline goals for 2026, with detailed financial results and guidance to be reported at the end of the month [2][3] - 2025 is highlighted as a year of excellent performance, with effective navigation of the operational environment and significant advancements in the company's growth strategy [3]